Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Apollo Commercial Real Estate Finance, Inc. (ARI) Stock Forecast 2025 - AI Price Prediction & Analysis

Apollo Commercial Real Estate Finance, Inc. (ARI) AI Stock Price Forecast & Investment Analysis

Apollo Commercial Real Estate Finance, Inc. Stock Price Chart and Technical Analysis

Loading Apollo Commercial Real Estate Finance, Inc. interactive price chart and technical analysis...

Apollo Commercial Real Estate Finance, Inc. (ARI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Apollo Commercial Real Estate Finance, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Apollo Commercial Real Estate Finance, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Apollo Commercial Real Estate Finance, Inc.: Apollo Commercial Real Estate Finance, Inc. operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

Apollo Commercial Real Estate Finance, Inc. (Stock Symbol: ARI) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Apollo Commercial Real Estate Finance, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Commercial Real Estate Finance, Inc.: With $268M in annual revenue and -39.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $268 million generating a -39.4% net profit margin .

Market Capitalization: $1385 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 7.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Apollo Commercial Real Estate Finance, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Apollo Commercial Real Estate Finance, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Apollo Commercial Real Estate Finance, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Apollo Commercial Real Estate Finance, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Apollo Commercial Real Estate Finance, Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

Apollo Commercial Real Estate Finance, Inc. strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $205 million annually, complemented by impressive -40.0% year-over-year cash flow growth.

Apollo Commercial Real Estate Finance, Inc. (ARI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Apollo Commercial Real Estate Finance, Inc. stock analysis.

Loading Apollo Commercial Real Estate Finance, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Apollo Commercial Real Estate Finance, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Apollo Commercial Real Estate Finance, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Apollo Commercial Real Estate Finance, Inc.: With a P/E ratio of 10.03, the market sees the stock as potentially undervalued.

P/E Ratio 10.03x
P/B Ratio 0.74x
Market Cap $1385M
Dividend Yield 10.03%
EPS $-0.15
Book Value/Share $13.40
Revenue/Share $1.93
FCF/Share $1.10
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Apollo Commercial Real Estate Finance, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Commercial Real Estate Finance, Inc.: An ROE of 7.2% indicates room for improvement in shareholder value creation.

ROE 7.2%
ROA 2.0%
Net Margin -39.4%
EBT Margin 67.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Apollo Commercial Real Estate Finance, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Apollo Commercial Real Estate Finance, Inc.:

D/E Ratio 0.89x
Financial Leverage 3.91x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Apollo Commercial Real Estate Finance, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Apollo Commercial Real Estate Finance, Inc.: Free cash flow of $205M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $205M
Free Cash Flow $205M
OCF Growth YoY -40.0%
FCF Growth YoY -40.0%
FCF/Sales 77.2%
CapEx/Sales 0.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Apollo Commercial Real Estate Finance, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Apollo Commercial Real Estate Finance, Inc.: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Understanding Financial Statement Data

What these metrics mean: Key figures from Apollo Commercial Real Estate Finance, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Apollo Commercial Real Estate Finance, Inc.: With annual revenue of $268M, Apollo Commercial Real Estate Finance, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $268M
SG&A Expense $25M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 2%
Total Liabilities 74%
Accounts Receivable 1%
Dividend & Shareholder Information
Dividends Per Share $1.00
Payout Ratio 0.7%
Shares Outstanding 139M
Growth Metrics (YoY)
EPS Growth -9.7%

Latest Apollo Commercial Real Estate Finance, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Apollo Commercial Real Estate Finance, Inc. (ARI) stock price and investment outlook.

📰 We are currently updating our news feed for Apollo Commercial Real Estate Finance, Inc.. Check back soon for the latest market analysis and company updates.

Apollo Commercial Real Estate Finance, Inc. Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of Apollo Commercial Real Estate Finance, Inc. against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1155M 14.7x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $1754M 9.0x 0.6x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3474M 16.4x 1.2x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3358M 16.2x 1.1x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4343M 20.4x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $157M 6.3x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $281M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 8.2x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $163M 7.2x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8435M 43.6x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2035M 10.7x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $11392M 13.6x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26517M 68.0x 2.3x
AGNCM Unlock Forecast - 30 Days FREE Trial $26217M 67.7x 2.3x
AGNCN Unlock Forecast - 30 Days FREE Trial $27214M 70.1x 2.4x
AGNCO Unlock Forecast - 30 Days FREE Trial $27000M 69.4x 2.4x
AGNCP Unlock Forecast - 30 Days FREE Trial $26624M 68.3x 2.3x
AHR Unlock Forecast - 30 Days FREE Trial $8163M 299.5x 3.1x
AHT Unlock Forecast - 30 Days FREE Trial $22M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $118M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $85M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $100M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $85M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $85M x x
AIV Unlock Forecast - 30 Days FREE Trial $786M 3.3x 12.7x
AKR Unlock Forecast - 30 Days FREE Trial $2587M 227.8x 1.2x
ALEX Unlock Forecast - 30 Days FREE Trial $1113M 15.2x 1.1x
ALX Unlock Forecast - 30 Days FREE Trial $1098M 29.9x 8.6x
AMH Unlock Forecast - 30 Days FREE Trial $11441M 22.3x 1.6x
AMH-PG Unlock Forecast - 30 Days FREE Trial $8535M x 1.2x
AMH-PH Unlock Forecast - 30 Days FREE Trial $8925M x 1.3x
AMT Unlock Forecast - 30 Days FREE Trial $83759M 28.5x 21.2x
APLE Unlock Forecast - 30 Days FREE Trial $2740M 15.6x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $7744M 55.8x 0.5x
ARI Unlock Forecast - 30 Days FREE Trial $1385M 10.0x 0.7x
ARR Unlock Forecast - 30 Days FREE Trial $1952M 30.2x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $2372M x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $25207M 21.6x 2.1x
BDN Unlock Forecast - 30 Days FREE Trial $545M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $731M 18.7x 2.3x
BFS-PD Unlock Forecast - 30 Days FREE Trial $511M 12.7x 1.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $506M 13.1x 1.6x
BHM Unlock Forecast - 30 Days FREE Trial $37M 15.0x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $181M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1030M x 4.9x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1310M x 6.2x
BMNM Unlock Forecast - 30 Days FREE Trial $20M x 0.9x
BNL Unlock Forecast - 30 Days FREE Trial $3298M 36.7x 1.1x
BRSP Unlock Forecast - 30 Days FREE Trial $726M -6.6x 0.7x
BRT Unlock Forecast - 30 Days FREE Trial $262M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $7711M 23.2x 2.6x
BXMT Unlock Forecast - 30 Days FREE Trial $3358M 31.3x 0.9x
BXP Unlock Forecast - 30 Days FREE Trial $10974M 2366.0x 2.2x
CBL Unlock Forecast - 30 Days FREE Trial $1095M 8.8x 3.1x
CCI Unlock Forecast - 30 Days FREE Trial $38837M 36.6x 5.5x
CDP Unlock Forecast - 30 Days FREE Trial $3288M 21.0x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $246M 46.0x 42.0x
CDR-PC Unlock Forecast - 30 Days FREE Trial $227M 41.3x 38.8x
CHCT Unlock Forecast - 30 Days FREE Trial $435M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $91M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $765M x 3.3x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $867M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CIM Unlock Forecast - 30 Days FREE Trial $1051M 18.9x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2031M 10.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2040M 10.8x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1803M 9.3x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1977M 10.1x 0.8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1808M 9.5x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1984M 10.1x 0.8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1005M x 1.7x
CLDT Unlock Forecast - 30 Days FREE Trial $319M 36.5x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $984M 108.6x 1.3x
CLPR Unlock Forecast - 30 Days FREE Trial $57M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1113M 152.1x 0.6x
COLD Unlock Forecast - 30 Days FREE Trial $3062M -26.5x 1.0x
CPT Unlock Forecast - 30 Days FREE Trial $11053M 41.1x 2.4x
CSR Unlock Forecast - 30 Days FREE Trial $1080M 35.5x 1.4x
CTO Unlock Forecast - 30 Days FREE Trial $586M 41.8x 1.1x
CTO-PA Unlock Forecast - 30 Days FREE Trial $694M x 1.3x
CTRE Unlock Forecast - 30 Days FREE Trial $8398M 32.1x 2.1x
CUBE Unlock Forecast - 30 Days FREE Trial $8353M 23.5x 3.0x
CUZ Unlock Forecast - 30 Days FREE Trial $4144M 71.9x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $1961M 18.0x 1.3x
DEA Unlock Forecast - 30 Days FREE Trial $1002M 72.3x 0.8x
DEI Unlock Forecast - 30 Days FREE Trial $1999M 90.0x 1.0x
DHC Unlock Forecast - 30 Days FREE Trial $1157M -1.7x 0.7x
DHCNI Unlock Forecast - 30 Days FREE Trial $4032M -10.4x 2.4x
DLR Unlock Forecast - 30 Days FREE Trial $56509M 40.4x 2.5x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7532M 5.6x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8247M 6.0x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7248M 5.5x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $11828M 78.3x 1.6x
DRH Unlock Forecast - 30 Days FREE Trial $1762M 27.5x 1.1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5179M 76.7x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $2023M 11.0x 3.5x
DX-PC Unlock Forecast - 30 Days FREE Trial $3785M 48.9x 6.5x
EARN Unlock Forecast - 30 Days FREE Trial $201M -11.6x 0.9x
EGP Unlock Forecast - 30 Days FREE Trial $9598M 38.7x 2.7x
ELME Unlock Forecast - 30 Days FREE Trial $1517M -114.5x 1.7x
ELS Unlock Forecast - 30 Days FREE Trial $11957M 20.1x 6.8x
EPR Unlock Forecast - 30 Days FREE Trial $3950M 19.8x 1.9x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1816M 10.3x 0.9x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2342M 13.1x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1582M 8.8x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6073M 25.3x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $72814M 68.0x 5.1x
EQR Unlock Forecast - 30 Days FREE Trial $23236M 20.1x 2.1x
ESBA Unlock Forecast - 30 Days FREE Trial $1871M 31.4x x
ESRT Unlock Forecast - 30 Days FREE Trial $1855M 53.2x 1.8x
ESS Unlock Forecast - 30 Days FREE Trial $16447M 19.4x 2.9x
EXR Unlock Forecast - 30 Days FREE Trial $27499M 29.0x 2.0x
FBRT Unlock Forecast - 30 Days FREE Trial $877M 9.2x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1751M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2440M 22.4x 1.6x
FISK Unlock Forecast - 30 Days FREE Trial $1836M x x
FPI Unlock Forecast - 30 Days FREE Trial $431M 6.3x 430760.1x
FR Unlock Forecast - 30 Days FREE Trial $7661M 32.3x 2.9x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8385M 24.2x 2.6x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1747M 5.3x 0.5x
FSP Unlock Forecast - 30 Days FREE Trial $106M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $330M 1175.4x 0.9x
GEDC Unlock Forecast - 30 Days FREE Trial $8M x x
GIPR Unlock Forecast - 30 Days FREE Trial $5M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $11855M 15.3x 2.6x
GMRE Unlock Forecast - 30 Days FREE Trial $441M 176.4x 0.9x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $328M 162.4x 0.7x
GNL Unlock Forecast - 30 Days FREE Trial $1791M -4.5x 1.1x
GNL-PA Unlock Forecast - 30 Days FREE Trial $4956M x 2.9x
GNL-PB Unlock Forecast - 30 Days FREE Trial $4734M x 2.8x
GNL-PD Unlock Forecast - 30 Days FREE Trial $5112M x 3.0x
GNL-PE Unlock Forecast - 30 Days FREE Trial $4984M x 2.9x
GPMT Unlock Forecast - 30 Days FREE Trial $133M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $944M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2576M x 2.9x
HHH Unlock Forecast - 30 Days FREE Trial $5130M 43.5x 1.4x
HIW Unlock Forecast - 30 Days FREE Trial $2909M 22.4x 1.2x
HLTC Unlock Forecast - 30 Days FREE Trial $213M x 0.3x
HST Unlock Forecast - 30 Days FREE Trial $11870M 16.1x 1.8x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $205M 17.4x 0.9x
IHT Unlock Forecast - 30 Days FREE Trial $11M -57.7x 2.8x
ILPT Unlock Forecast - 30 Days FREE Trial $384M -2.3x 0.8x
IMPM Unlock Forecast - 30 Days FREE Trial $4M x x
INN Unlock Forecast - 30 Days FREE Trial $533M 336.2x 0.6x
INN-PE Unlock Forecast - 30 Days FREE Trial $2101M 241.6x 2.4x
INN-PF Unlock Forecast - 30 Days FREE Trial $2168M 369.2x 2.5x
INRE Unlock Forecast - 30 Days FREE Trial $379M x 1.1x
IOR Unlock Forecast - 30 Days FREE Trial $72M 16.8x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $24914M 156.4x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $3952M 177.3x 1.1x
IVR Unlock Forecast - 30 Days FREE Trial $591M 11.1x 0.8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1717M 40.1x 2.2x
IVT Unlock Forecast - 30 Days FREE Trial $2175M 18.3x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1078M -11.3x 0.6x
KBSR Unlock Forecast - 30 Days FREE Trial $180M x 0.9x
KIM Unlock Forecast - 30 Days FREE Trial $13632M 22.7x 1.3x
KIM-PL Unlock Forecast - 30 Days FREE Trial $13764M 23.8x 1.3x
KIM-PM Unlock Forecast - 30 Days FREE Trial $13950M 24.5x 1.3x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39903M 65.8x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4824M 14.9x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $557M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1179M x 1.0x
KRG Unlock Forecast - 30 Days FREE Trial $4907M 46.7x 1.6x
LADR Unlock Forecast - 30 Days FREE Trial $1383M 17.5x 0.9x
LAMR Unlock Forecast - 30 Days FREE Trial $13514M 31.2x 13.1x
LAND Unlock Forecast - 30 Days FREE Trial $334M 33.9x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $905M -119.7x 1.4x
LANDO Unlock Forecast - 30 Days FREE Trial $690M -104.0x 1.0x
LANDP Unlock Forecast - 30 Days FREE Trial $689M -103.5x 1.0x
LFT Unlock Forecast - 30 Days FREE Trial $84M 6.5x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1092M 74.5x 4.8x
LINE Unlock Forecast - 30 Days FREE Trial $8065M x 1.0x
LOAN Unlock Forecast - 30 Days FREE Trial $54M 10.9x 1.3x
LTC Unlock Forecast - 30 Days FREE Trial $1677M 49.5x 1.8x
LXP Unlock Forecast - 30 Days FREE Trial $14401M 122.6x 7.0x
LXP-PC Unlock Forecast - 30 Days FREE Trial $13827M 162.3x 6.7x
MAA Unlock Forecast - 30 Days FREE Trial $15416M 27.7x 2.7x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6238M 11.4x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4549M -64.7x 1.8x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.5x
MDV Unlock Forecast - 30 Days FREE Trial $171M -24.6x 1.0x
MDV-PA Unlock Forecast - 30 Days FREE Trial $288M x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $981M 7.6x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2552M 20.2x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2562M 20.4x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2130M 16.6x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2421M 19.1x 1.3x
MITN Unlock Forecast - 30 Days FREE Trial $796M 16.3x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $798M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $265M 5.3x 0.5x
MITT-PA Unlock Forecast - 30 Days FREE Trial $704M 14.4x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $698M 13.6x 1.3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $792M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $7M x 0.1x
MPW Unlock Forecast - 30 Days FREE Trial $3294M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3582M 24.3x 2.4x
NHPAP Unlock Forecast - 30 Days FREE Trial $528M x 0.8x
NHPBP Unlock Forecast - 30 Days FREE Trial $513M x 0.8x
NLCP Unlock Forecast - 30 Days FREE Trial $257M 9.8x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $371M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $15576M 10.4x 1.0x
NLY-PF Unlock Forecast - 30 Days FREE Trial $17449M x 1.2x
NLY-PG Unlock Forecast - 30 Days FREE Trial $17197M x 1.2x
NLY-PI Unlock Forecast - 30 Days FREE Trial $17449M x 1.2x
NNN Unlock Forecast - 30 Days FREE Trial $7635M 19.5x 1.7x
NREF Unlock Forecast - 30 Days FREE Trial $261M 2.3x 2.0x
NREF-PA Unlock Forecast - 30 Days FREE Trial $410M 4.8x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2280M 33.7x 2.3x
NSA-PA Unlock Forecast - 30 Days FREE Trial $1640M x 1.7x
NSA-PB Unlock Forecast - 30 Days FREE Trial $1603M x 1.7x
NTST Unlock Forecast - 30 Days FREE Trial $1467M 7928.3x 1.1x
NXDT Unlock Forecast - 30 Days FREE Trial $142M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $688M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $770M 16.6x 2.4x
NYC Unlock Forecast - 30 Days FREE Trial $21M -0.1x 0.3x
O Unlock Forecast - 30 Days FREE Trial $53795M 55.9x 1.4x
OGCP Unlock Forecast - 30 Days FREE Trial $1841M x x
OLP Unlock Forecast - 30 Days FREE Trial $427M 12.7x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $127M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $1091M 17.8x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3898M 31.4x 7.2x
PCH Unlock Forecast - 30 Days FREE Trial $3042M 47.4x 1.6x
PCOK Unlock Forecast - 30 Days FREE Trial $148M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1228M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2108M x 0.8x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2120M x 0.8x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2152M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $1948M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4385M 53.5x 1.9x
PGRE Unlock Forecast - 30 Days FREE Trial $1460M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $247M 169.3x 1.1x
PKST Unlock Forecast - 30 Days FREE Trial $508M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $118850M 37.1x 2.3x
PLDGP Unlock Forecast - 30 Days FREE Trial $52005M 15.0x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1105M 9.1x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2106M 19.7x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2056M 19.8x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1659M 15.6x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2244M 21.2x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2207M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2230M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $47860M 25.3x 5.1x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3814M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3678M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4074M 2.4x 0.4x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3471M 2.1x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3348M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3393M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3291M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $2954M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2771M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2790M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2852M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2818M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2852M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $2913M 1.7x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $364M 147.2x 1.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $14M x 2.2x
RC Unlock Forecast - 30 Days FREE Trial $424M -13.0x 0.2x
RCB Unlock Forecast - 30 Days FREE Trial $3952M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4014M -45.2x 2.3x
RCD Unlock Forecast - 30 Days FREE Trial $3819M x 2.2x
RC-PC Unlock Forecast - 30 Days FREE Trial $2266M x 1.3x
RC-PE Unlock Forecast - 30 Days FREE Trial $2279M x 1.3x
REFI Unlock Forecast - 30 Days FREE Trial $269M 7.5x 0.9x
REG Unlock Forecast - 30 Days FREE Trial $12519M 38.5x 1.8x
REGCO Unlock Forecast - 30 Days FREE Trial $4138M x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4341M x 0.6x
REXR Unlock Forecast - 30 Days FREE Trial $9482M 27.9x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5301M 17.1x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5115M 15.3x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $5780M 23.9x 7.6x
RITM Unlock Forecast - 30 Days FREE Trial $6285M 7.0x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14005M 16.9x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13910M 16.8x 1.6x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13578M 16.4x 1.6x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13528M 16.3x 1.6x
RLJ Unlock Forecast - 30 Days FREE Trial $1098M 32.8x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3791M 65.8x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $122M -0.8x 0.4x
RPT-PC Unlock Forecast - 30 Days FREE Trial $1136M x 3.9x
RWT Unlock Forecast - 30 Days FREE Trial $721M 31.3x 0.7x
RWTN Unlock Forecast - 30 Days FREE Trial $3169M x 3.2x
RWTO Unlock Forecast - 30 Days FREE Trial $3124M x 3.1x
RWTP Unlock Forecast - 30 Days FREE Trial $3078M x 3.1x
RWT-PA Unlock Forecast - 30 Days FREE Trial $3080M x 3.1x
SACH Unlock Forecast - 30 Days FREE Trial $49M 21.3x 0.3x
SACH-PA Unlock Forecast - 30 Days FREE Trial $889M x 5.1x
SAFE Unlock Forecast - 30 Days FREE Trial $986M 8.8x 0.4x
SBAC Unlock Forecast - 30 Days FREE Trial $20242M 23.6x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4807M 27.5x 1.7x
SCCC Unlock Forecast - 30 Days FREE Trial $1192M 361.5x 6.8x
SCCD Unlock Forecast - 30 Days FREE Trial $1140M 304.5x 6.5x
SCCE Unlock Forecast - 30 Days FREE Trial $1104M 304.8x 6.3x
SCCF Unlock Forecast - 30 Days FREE Trial $1102M 279.9x 6.3x
SCCG Unlock Forecast - 30 Days FREE Trial $1104M 325.2x 6.3x
SELF Unlock Forecast - 30 Days FREE Trial $58M 22.8x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $132M 10.5x 0.5x
SILA Unlock Forecast - 30 Days FREE Trial $1282M 32.7x 1.0x
SITC Unlock Forecast - 30 Days FREE Trial $380M 1.3x 1.2x
SKT Unlock Forecast - 30 Days FREE Trial $3694M 45.4x 5.3x
SLG Unlock Forecast - 30 Days FREE Trial $3025M 177.8x 0.8x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1523M x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $1014M x 0.8x
SOHO Unlock Forecast - 30 Days FREE Trial $44M -1.4x 1.2x
SOHOB Unlock Forecast - 30 Days FREE Trial $351M -21.4x 9.5x
SOHON Unlock Forecast - 30 Days FREE Trial $314M -21.8x 8.6x
SOHOO Unlock Forecast - 30 Days FREE Trial $358M -25.6x 9.7x
SPG Unlock Forecast - 30 Days FREE Trial $59593M 26.5x 25.4x
SPG-PJ Unlock Forecast - 30 Days FREE Trial $17754M x 7.6x
SQFT Unlock Forecast - 30 Days FREE Trial $38M 1.2x 1.1x
SQFTP Unlock Forecast - 30 Days FREE Trial $139M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7244M 30.1x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $26M 37.8x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $172M 24.4x 12.0x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6755M 18.4x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15850M 15.1x 2.3x
SUNS Unlock Forecast - 30 Days FREE Trial $135M 13.4x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $307M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $389M 58.9x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $203M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $580M x 3.6x
TRTX Unlock Forecast - 30 Days FREE Trial $708M 10.6x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1421M 20.7x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $1073M 15.2x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2647M x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2445M x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2360M x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2489M x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11643M 77.8x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $550M 30.7x 3.5x
UMH Unlock Forecast - 30 Days FREE Trial $1303M 48.5x 1.4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1890M 63.1x 2.0x
VICI Unlock Forecast - 30 Days FREE Trial $29638M 10.6x 1.1x
VNO Unlock Forecast - 30 Days FREE Trial $6687M 7.4x 1.1x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3396M 4.0x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3399M 4.0x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3332M 4.0x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2862M 3.3x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $12772M 17.9x 2.1x
VRE Unlock Forecast - 30 Days FREE Trial $1361M 21.6x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $37842M 159.0x 3.1x
WELL Unlock Forecast - 30 Days FREE Trial $139770M 145.5x 3.6x
WHLR Unlock Forecast - 30 Days FREE Trial $3M 1.7x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $32M 17.5x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $85M 56.0x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $4M 2.0x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14531M 39.8x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $675M 15.2x 1.5x
WY Unlock Forecast - 30 Days FREE Trial $15635M 47.2x 1.7x

Frequently Asked Questions - Apollo Commercial Real Estate Finance, Inc. Stock Forecast

How accurate are Apollo Commercial Real Estate Finance, Inc. stock predictions?

Our AI model shows a 2% Spearman correlation coefficient for ARI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Apollo Commercial Real Estate Finance, Inc. stock price forecasts?

Our analysis considers Apollo Commercial Real Estate Finance, Inc.'s financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Apollo Commercial Real Estate Finance, Inc. a good investment in 2025?

Based on our AI analysis, Apollo Commercial Real Estate Finance, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Apollo Commercial Real Estate Finance, Inc. forecasts updated?

Apollo Commercial Real Estate Finance, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Apollo Commercial Real Estate Finance, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Apollo Commercial Real Estate Finance, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...